Global Drug Safety and Pharmacovigilance Software Market Size, Status and Forecast 2022

SKU ID :QYR-19534635 | Published Date: 15-Nov-2021 | No. of pages: 108
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Drug Safety and Pharmacovigilance Software Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 ADR Reporting 1.2.3 Drug Safety Audits 1.2.4 Issue Tracking 1.2.5 Fully Integrated Software 1.3 Market by Application 1.3.1 Global Drug Safety and Pharmacovigilance Software Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Pharma & Biotech Companies 1.3.3 CROs 1.3.4 BPOs 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Drug Safety and Pharmacovigilance Software Market Perspective (2016-2027) 2.2 Drug Safety and Pharmacovigilance Software Growth Trends by Regions 2.2.1 Drug Safety and Pharmacovigilance Software Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Drug Safety and Pharmacovigilance Software Historic Market Share by Regions (2016-2021) 2.2.3 Drug Safety and Pharmacovigilance Software Forecasted Market Size by Regions (2022-2027) 2.3 Drug Safety and Pharmacovigilance Software Industry Dynamic 2.3.1 Drug Safety and Pharmacovigilance Software Market Trends 2.3.2 Drug Safety and Pharmacovigilance Software Market Drivers 2.3.3 Drug Safety and Pharmacovigilance Software Market Challenges 2.3.4 Drug Safety and Pharmacovigilance Software Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Drug Safety and Pharmacovigilance Software Players by Revenue 3.1.1 Global Top Drug Safety and Pharmacovigilance Software Players by Revenue (2016-2021) 3.1.2 Global Drug Safety and Pharmacovigilance Software Revenue Market Share by Players (2016-2021) 3.2 Global Drug Safety and Pharmacovigilance Software Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Drug Safety and Pharmacovigilance Software Revenue 3.4 Global Drug Safety and Pharmacovigilance Software Market Concentration Ratio 3.4.1 Global Drug Safety and Pharmacovigilance Software Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Drug Safety and Pharmacovigilance Software Revenue in 2020 3.5 Drug Safety and Pharmacovigilance Software Key Players Head office and Area Served 3.6 Key Players Drug Safety and Pharmacovigilance Software Product Solution and Service 3.7 Date of Enter into Drug Safety and Pharmacovigilance Software Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Drug Safety and Pharmacovigilance Software Breakdown Data by Type 4.1 Global Drug Safety and Pharmacovigilance Software Historic Market Size by Type (2016-2021) 4.2 Global Drug Safety and Pharmacovigilance Software Forecasted Market Size by Type (2022-2027) 5 Drug Safety and Pharmacovigilance Software Breakdown Data by Application 5.1 Global Drug Safety and Pharmacovigilance Software Historic Market Size by Application (2016-2021) 5.2 Global Drug Safety and Pharmacovigilance Software Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Drug Safety and Pharmacovigilance Software Market Size (2016-2027) 6.2 North America Drug Safety and Pharmacovigilance Software Market Size by Type 6.2.1 North America Drug Safety and Pharmacovigilance Software Market Size by Type (2016-2021) 6.2.2 North America Drug Safety and Pharmacovigilance Software Market Size by Type (2022-2027) 6.2.3 North America Drug Safety and Pharmacovigilance Software Market Size by Type (2016-2027) 6.3 North America Drug Safety and Pharmacovigilance Software Market Size by Application 6.3.1 North America Drug Safety and Pharmacovigilance Software Market Size by Application (2016-2021) 6.3.2 North America Drug Safety and Pharmacovigilance Software Market Size by Application (2022-2027) 6.3.3 North America Drug Safety and Pharmacovigilance Software Market Size by Application (2016-2027) 6.4 North America Drug Safety and Pharmacovigilance Software Market Size by Country 6.4.1 North America Drug Safety and Pharmacovigilance Software Market Size by Country (2016-2021) 6.4.2 North America Drug Safety and Pharmacovigilance Software Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Drug Safety and Pharmacovigilance Software Market Size (2016-2027) 7.2 Europe Drug Safety and Pharmacovigilance Software Market Size by Type 7.2.1 Europe Drug Safety and Pharmacovigilance Software Market Size by Type (2016-2021) 7.2.2 Europe Drug Safety and Pharmacovigilance Software Market Size by Type (2022-2027) 7.2.3 Europe Drug Safety and Pharmacovigilance Software Market Size by Type (2016-2027) 7.3 Europe Drug Safety and Pharmacovigilance Software Market Size by Application 7.3.1 Europe Drug Safety and Pharmacovigilance Software Market Size by Application (2016-2021) 7.3.2 Europe Drug Safety and Pharmacovigilance Software Market Size by Application (2022-2027) 7.3.3 Europe Drug Safety and Pharmacovigilance Software Market Size by Application (2016-2027) 7.4 Europe Drug Safety and Pharmacovigilance Software Market Size by Country 7.4.1 Europe Drug Safety and Pharmacovigilance Software Market Size by Country (2016-2021) 7.4.2 Europe Drug Safety and Pharmacovigilance Software Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Drug Safety and Pharmacovigilance Software Market Size (2016-2027) 8.2 Asia-Pacific Drug Safety and Pharmacovigilance Software Market Size by Type 8.2.1 Asia-Pacific Drug Safety and Pharmacovigilance Software Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Drug Safety and Pharmacovigilance Software Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Drug Safety and Pharmacovigilance Software Market Size by Type (2016-2027) 8.3 Asia-Pacific Drug Safety and Pharmacovigilance Software Market Size by Application 8.3.1 Asia-Pacific Drug Safety and Pharmacovigilance Software Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Drug Safety and Pharmacovigilance Software Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Drug Safety and Pharmacovigilance Software Market Size by Application (2016-2027) 8.4 Asia-Pacific Drug Safety and Pharmacovigilance Software Market Size by Region 8.4.1 Asia-Pacific Drug Safety and Pharmacovigilance Software Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Drug Safety and Pharmacovigilance Software Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Drug Safety and Pharmacovigilance Software Market Size (2016-2027) 9.2 Latin America Drug Safety and Pharmacovigilance Software Market Size by Type 9.2.1 Latin America Drug Safety and Pharmacovigilance Software Market Size by Type (2016-2021) 9.2.2 Latin America Drug Safety and Pharmacovigilance Software Market Size by Type (2022-2027) 9.2.3 Latin America Drug Safety and Pharmacovigilance Software Market Size by Type (2016-2027) 9.3 Latin America Drug Safety and Pharmacovigilance Software Market Size by Application 9.3.1 Latin America Drug Safety and Pharmacovigilance Software Market Size by Application (2016-2021) 9.3.2 Latin America Drug Safety and Pharmacovigilance Software Market Size by Application (2022-2027) 9.3.3 Latin America Drug Safety and Pharmacovigilance Software Market Size by Application (2016-2027) 9.4 Latin America Drug Safety and Pharmacovigilance Software Market Size by Country 9.4.1 Latin America Drug Safety and Pharmacovigilance Software Market Size by Country (2016-2021) 9.4.2 Latin America Drug Safety and Pharmacovigilance Software Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Drug Safety and Pharmacovigilance Software Market Size (2016-2027) 10.2 Middle East & Africa Drug Safety and Pharmacovigilance Software Market Size by Type 10.2.1 Middle East & Africa Drug Safety and Pharmacovigilance Software Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Drug Safety and Pharmacovigilance Software Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Drug Safety and Pharmacovigilance Software Market Size by Type (2016-2027) 10.3 Middle East & Africa Drug Safety and Pharmacovigilance Software Market Size by Application 10.3.1 Middle East & Africa Drug Safety and Pharmacovigilance Software Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Drug Safety and Pharmacovigilance Software Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Drug Safety and Pharmacovigilance Software Market Size by Application (2016-2027) 10.4 Middle East & Africa Drug Safety and Pharmacovigilance Software Market Size by Country 10.4.1 Middle East & Africa Drug Safety and Pharmacovigilance Software Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Drug Safety and Pharmacovigilance Software Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 AB cube 11.1.1 AB cube Company Details 11.1.2 AB cube Business Overview 11.1.3 AB cube Drug Safety and Pharmacovigilance Software Introduction 11.1.4 AB cube Revenue in Drug Safety and Pharmacovigilance Software Business (2016-2021) 11.1.5 AB cube Recent Development 11.2 Max Application 11.2.1 Max Application Company Details 11.2.2 Max Application Business Overview 11.2.3 Max Application Drug Safety and Pharmacovigilance Software Introduction 11.2.4 Max Application Revenue in Drug Safety and Pharmacovigilance Software Business (2016-2021) 11.2.5 Max Application Recent Development 11.3 Ennov Solutions Inc 11.3.1 Ennov Solutions Inc Company Details 11.3.2 Ennov Solutions Inc Business Overview 11.3.3 Ennov Solutions Inc Drug Safety and Pharmacovigilance Software Introduction 11.3.4 Ennov Solutions Inc Revenue in Drug Safety and Pharmacovigilance Software Business (2016-2021) 11.3.5 Ennov Solutions Inc Recent Development 11.4 ArisGlobal 11.4.1 ArisGlobal Company Details 11.4.2 ArisGlobal Business Overview 11.4.3 ArisGlobal Drug Safety and Pharmacovigilance Software Introduction 11.4.4 ArisGlobal Revenue in Drug Safety and Pharmacovigilance Software Business (2016-2021) 11.4.5 ArisGlobal Recent Development 11.5 EXTEDO GmbH 11.5.1 EXTEDO GmbH Company Details 11.5.2 EXTEDO GmbH Business Overview 11.5.3 EXTEDO GmbH Drug Safety and Pharmacovigilance Software Introduction 11.5.4 EXTEDO GmbH Revenue in Drug Safety and Pharmacovigilance Software Business (2016-2021) 11.5.5 EXTEDO GmbH Recent Development 11.6 Online Business Applications Inc 11.6.1 Online Business Applications Inc Company Details 11.6.2 Online Business Applications Inc Business Overview 11.6.3 Online Business Applications Inc Drug Safety and Pharmacovigilance Software Introduction 11.6.4 Online Business Applications Inc Revenue in Drug Safety and Pharmacovigilance Software Business (2016-2021) 11.6.5 Online Business Applications Inc Recent Development 11.7 Oracle Corporation 11.7.1 Oracle Corporation Company Details 11.7.2 Oracle Corporation Business Overview 11.7.3 Oracle Corporation Drug Safety and Pharmacovigilance Software Introduction 11.7.4 Oracle Corporation Revenue in Drug Safety and Pharmacovigilance Software Business (2016-2021) 11.7.5 Oracle Corporation Recent Development 11.8 Sparta Systems, Inc. 11.8.1 Sparta Systems, Inc. Company Details 11.8.2 Sparta Systems, Inc. Business Overview 11.8.3 Sparta Systems, Inc. Drug Safety and Pharmacovigilance Software Introduction 11.8.4 Sparta Systems, Inc. Revenue in Drug Safety and Pharmacovigilance Software Business (2016-2021) 11.8.5 Sparta Systems, Inc. Recent Development 11.9 United BioSource Corporation 11.9.1 United BioSource Corporation Company Details 11.9.2 United BioSource Corporation Business Overview 11.9.3 United BioSource Corporation Drug Safety and Pharmacovigilance Software Introduction 11.9.4 United BioSource Corporation Revenue in Drug Safety and Pharmacovigilance Software Business (2016-2021) 11.9.5 United BioSource Corporation Recent Development 11.10 Sarjen Systems 11.10.1 Sarjen Systems Company Details 11.10.2 Sarjen Systems Business Overview 11.10.3 Sarjen Systems Drug Safety and Pharmacovigilance Software Introduction 11.10.4 Sarjen Systems Revenue in Drug Safety and Pharmacovigilance Software Business (2016-2021) 11.10.5 Sarjen Systems Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
List of Tables Table 1. Global Drug Safety and Pharmacovigilance Software Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of ADR Reporting Table 3. Key Players of Drug Safety Audits Table 4. Key Players of Issue Tracking Table 5. Key Players of Fully Integrated Software Table 6. Global Drug Safety and Pharmacovigilance Software Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Drug Safety and Pharmacovigilance Software Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Drug Safety and Pharmacovigilance Software Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Drug Safety and Pharmacovigilance Software Market Share by Regions (2016-2021) Table 10. Global Drug Safety and Pharmacovigilance Software Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Drug Safety and Pharmacovigilance Software Market Share by Regions (2022-2027) Table 12. Drug Safety and Pharmacovigilance Software Market Trends Table 13. Drug Safety and Pharmacovigilance Software Market Drivers Table 14. Drug Safety and Pharmacovigilance Software Market Challenges Table 15. Drug Safety and Pharmacovigilance Software Market Restraints Table 16. Global Drug Safety and Pharmacovigilance Software Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Drug Safety and Pharmacovigilance Software Market Share by Players (2016-2021) Table 18. Global Top Drug Safety and Pharmacovigilance Software Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Safety and Pharmacovigilance Software as of 2020) Table 19. Ranking of Global Top Drug Safety and Pharmacovigilance Software Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Drug Safety and Pharmacovigilance Software Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Drug Safety and Pharmacovigilance Software Product Solution and Service Table 23. Date of Enter into Drug Safety and Pharmacovigilance Software Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Drug Safety and Pharmacovigilance Software Market Size by Type (2016-2021) (US$ Million) Table 26. Global Drug Safety and Pharmacovigilance Software Revenue Market Share by Type (2016-2021) Table 27. Global Drug Safety and Pharmacovigilance Software Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Drug Safety and Pharmacovigilance Software Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Drug Safety and Pharmacovigilance Software Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Drug Safety and Pharmacovigilance Software Revenue Market Share by Application (2016-2021) Table 31. Global Drug Safety and Pharmacovigilance Software Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Drug Safety and Pharmacovigilance Software Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Drug Safety and Pharmacovigilance Software Market Size by Type (2016-2021) (US$ Million) Table 34. North America Drug Safety and Pharmacovigilance Software Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Drug Safety and Pharmacovigilance Software Market Size by Application (2016-2021) (US$ Million) Table 36. North America Drug Safety and Pharmacovigilance Software Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Drug Safety and Pharmacovigilance Software Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Drug Safety and Pharmacovigilance Software Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Drug Safety and Pharmacovigilance Software Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Drug Safety and Pharmacovigilance Software Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Drug Safety and Pharmacovigilance Software Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Drug Safety and Pharmacovigilance Software Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Drug Safety and Pharmacovigilance Software Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Drug Safety and Pharmacovigilance Software Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Drug Safety and Pharmacovigilance Software Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Drug Safety and Pharmacovigilance Software Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Drug Safety and Pharmacovigilance Software Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Drug Safety and Pharmacovigilance Software Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Drug Safety and Pharmacovigilance Software Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Drug Safety and Pharmacovigilance Software Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Drug Safety and Pharmacovigilance Software Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Drug Safety and Pharmacovigilance Software Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Drug Safety and Pharmacovigilance Software Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Drug Safety and Pharmacovigilance Software Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Drug Safety and Pharmacovigilance Software Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Drug Safety and Pharmacovigilance Software Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Drug Safety and Pharmacovigilance Software Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Drug Safety and Pharmacovigilance Software Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Drug Safety and Pharmacovigilance Software Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Drug Safety and Pharmacovigilance Software Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Drug Safety and Pharmacovigilance Software Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Drug Safety and Pharmacovigilance Software Market Size by Country (2022-2027) & (US$ Million) Table 63. AB cube Company Details Table 64. AB cube Business Overview Table 65. AB cube Drug Safety and Pharmacovigilance Software Product Table 66. AB cube Revenue in Drug Safety and Pharmacovigilance Software Business (2016-2021) & (US$ Million) Table 67. AB cube Recent Development Table 68. Max Application Company Details Table 69. Max Application Business Overview Table 70. Max Application Drug Safety and Pharmacovigilance Software Product Table 71. Max Application Revenue in Drug Safety and Pharmacovigilance Software Business (2016-2021) & (US$ Million) Table 72. Max Application Recent Development Table 73. Ennov Solutions Inc Company Details Table 74. Ennov Solutions Inc Business Overview Table 75. Ennov Solutions Inc Drug Safety and Pharmacovigilance Software Product Table 76. Ennov Solutions Inc Revenue in Drug Safety and Pharmacovigilance Software Business (2016-2021) & (US$ Million) Table 77. Ennov Solutions Inc Recent Development Table 78. ArisGlobal Company Details Table 79. ArisGlobal Business Overview Table 80. ArisGlobal Drug Safety and Pharmacovigilance Software Product Table 81. ArisGlobal Revenue in Drug Safety and Pharmacovigilance Software Business (2016-2021) & (US$ Million) Table 82. ArisGlobal Recent Development Table 83. EXTEDO GmbH Company Details Table 84. EXTEDO GmbH Business Overview Table 85. EXTEDO GmbH Drug Safety and Pharmacovigilance Software Product Table 86. EXTEDO GmbH Revenue in Drug Safety and Pharmacovigilance Software Business (2016-2021) & (US$ Million) Table 87. EXTEDO GmbH Recent Development Table 88. Online Business Applications Inc Company Details Table 89. Online Business Applications Inc Business Overview Table 90. Online Business Applications Inc Drug Safety and Pharmacovigilance Software Product Table 91. Online Business Applications Inc Revenue in Drug Safety and Pharmacovigilance Software Business (2016-2021) & (US$ Million) Table 92. Online Business Applications Inc Recent Development Table 93. Oracle Corporation Company Details Table 94. Oracle Corporation Business Overview Table 95. Oracle Corporation Drug Safety and Pharmacovigilance Software Product Table 96. Oracle Corporation Revenue in Drug Safety and Pharmacovigilance Software Business (2016-2021) & (US$ Million) Table 97. Oracle Corporation Recent Development Table 98. Sparta Systems, Inc. Company Details Table 99. Sparta Systems, Inc. Business Overview Table 100. Sparta Systems, Inc. Revenue in Drug Safety and Pharmacovigilance Software Business (2016-2021) & (US$ Million) Table 101. Sparta Systems, Inc. Recent Development Table 102. United BioSource Corporation Company Details Table 103. United BioSource Corporation Business Overview Table 104. United BioSource Corporation Drug Safety and Pharmacovigilance Software Product Table 105. United BioSource Corporation Revenue in Drug Safety and Pharmacovigilance Software Business (2016-2021) & (US$ Million) Table 106. United BioSource Corporation Recent Development Table 107. Sarjen Systems Company Details Table 108. Sarjen Systems Business Overview Table 109. Sarjen Systems Drug Safety and Pharmacovigilance Software Product Table 110. Sarjen Systems Revenue in Drug Safety and Pharmacovigilance Software Business (2016-2021) & (US$ Million) Table 111. Sarjen Systems Recent Development Table 112. Research Programs/Design for This Report Table 113. Key Data Information from Secondary Sources Table 114. Key Data Information from Primary Sources List of Figures Figure 1. Global Drug Safety and Pharmacovigilance Software Market Share by Type: 2020 VS 2027 Figure 2. ADR Reporting Features Figure 3. Drug Safety Audits Features Figure 4. Issue Tracking Features Figure 5. Fully Integrated Software Features Figure 6. Global Drug Safety and Pharmacovigilance Software Market Share by Application: 2020 VS 2027 Figure 7. Pharma & Biotech Companies Case Studies Figure 8. CROs Case Studies Figure 9. BPOs Case Studies Figure 10. Others Case Studies Figure 11. Drug Safety and Pharmacovigilance Software Report Years Considered Figure 12. Global Drug Safety and Pharmacovigilance Software Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 13. Global Drug Safety and Pharmacovigilance Software Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global Drug Safety and Pharmacovigilance Software Market Share by Regions: 2020 VS 2027 Figure 15. Global Drug Safety and Pharmacovigilance Software Market Share by Regions (2022-2027) Figure 16. Global Drug Safety and Pharmacovigilance Software Market Share by Players in 2020 Figure 17. Global Top Drug Safety and Pharmacovigilance Software Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Safety and Pharmacovigilance Software as of 2020 Figure 18. The Top 10 and 5 Players Market Share by Drug Safety and Pharmacovigilance Software Revenue in 2020 Figure 19. Global Drug Safety and Pharmacovigilance Software Revenue Market Share by Type (2016-2021) Figure 20. Global Drug Safety and Pharmacovigilance Software Revenue Market Share by Type (2022-2027) Figure 21. North America Drug Safety and Pharmacovigilance Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 22. North America Drug Safety and Pharmacovigilance Software Market Share by Type (2016-2027) Figure 23. North America Drug Safety and Pharmacovigilance Software Market Share by Application (2016-2027) Figure 24. North America Drug Safety and Pharmacovigilance Software Market Share by Country (2016-2027) Figure 25. United States Drug Safety and Pharmacovigilance Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Canada Drug Safety and Pharmacovigilance Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Drug Safety and Pharmacovigilance Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe Drug Safety and Pharmacovigilance Software Market Share by Type (2016-2027) Figure 29. Europe Drug Safety and Pharmacovigilance Software Market Share by Application (2016-2027) Figure 30. Europe Drug Safety and Pharmacovigilance Software Market Share by Country (2016-2027) Figure 31. Germany Drug Safety and Pharmacovigilance Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. France Drug Safety and Pharmacovigilance Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. U.K. Drug Safety and Pharmacovigilance Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Italy Drug Safety and Pharmacovigilance Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Russia Drug Safety and Pharmacovigilance Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Nordic Drug Safety and Pharmacovigilance Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Drug Safety and Pharmacovigilance Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific Drug Safety and Pharmacovigilance Software Market Share by Type (2016-2027) Figure 39. Asia-Pacific Drug Safety and Pharmacovigilance Software Market Share by Application (2016-2027) Figure 40. Asia-Pacific Drug Safety and Pharmacovigilance Software Market Share by Region (2016-2027) Figure 41. China Drug Safety and Pharmacovigilance Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Japan Drug Safety and Pharmacovigilance Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. South Korea Drug Safety and Pharmacovigilance Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Southeast Asia Drug Safety and Pharmacovigilance Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. India Drug Safety and Pharmacovigilance Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Australia Drug Safety and Pharmacovigilance Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Drug Safety and Pharmacovigilance Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America Drug Safety and Pharmacovigilance Software Market Share by Type (2016-2027) Figure 49. Latin America Drug Safety and Pharmacovigilance Software Market Share by Application (2016-2027) Figure 50. Latin America Drug Safety and Pharmacovigilance Software Market Share by Country (2016-2027) Figure 51. Mexico Drug Safety and Pharmacovigilance Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Brazil Drug Safety and Pharmacovigilance Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Drug Safety and Pharmacovigilance Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa Drug Safety and Pharmacovigilance Software Market Share by Type (2016-2027) Figure 55. Middle East & Africa Drug Safety and Pharmacovigilance Software Market Share by Application (2016-2027) Figure 56. Middle East & Africa Drug Safety and Pharmacovigilance Software Market Share by Country (2016-2027) Figure 57. Turkey Drug Safety and Pharmacovigilance Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Saudi Arabia Drug Safety and Pharmacovigilance Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. UAE Drug Safety and Pharmacovigilance Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. AB cube Revenue Growth Rate in Drug Safety and Pharmacovigilance Software Business (2016-2021) Figure 61. Max Application Revenue Growth Rate in Drug Safety and Pharmacovigilance Software Business (2016-2021) Figure 62. Ennov Solutions Inc Revenue Growth Rate in Drug Safety and Pharmacovigilance Software Business (2016-2021) Figure 63. ArisGlobal Revenue Growth Rate in Drug Safety and Pharmacovigilance Software Business (2016-2021) Figure 64. EXTEDO GmbH Revenue Growth Rate in Drug Safety and Pharmacovigilance Software Business (2016-2021) Figure 65. Online Business Applications Inc Revenue Growth Rate in Drug Safety and Pharmacovigilance Software Business (2016-2021) Figure 66. Oracle Corporation Revenue Growth Rate in Drug Safety and Pharmacovigilance Software Business (2016-2021) Figure 67. Sparta Systems, Inc. Revenue Growth Rate in Drug Safety and Pharmacovigilance Software Business (2016-2021) Figure 68. United BioSource Corporation Revenue Growth Rate in Drug Safety and Pharmacovigilance Software Business (2016-2021) Figure 69. Sarjen Systems Revenue Growth Rate in Drug Safety and Pharmacovigilance Software Business (2016-2021) Figure 70. Bottom-up and Top-down Approaches for This Report Figure 71. Data Triangulation Figure 72. Key Executives Interviewed
AB cube Max Application Ennov Solutions Inc ArisGlobal EXTEDO GmbH Online Business Applications Inc Oracle Corporation Sparta Systems, Inc. United BioSource Corporation Sarjen Systems
  • PRICE
  • $3900
    $7800
    $5850
    Buy Now

Our Clients